Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 293


HaploSNP affinities and linkage map positions illuminate subgenome composition in the octoploid, cultivated strawberry (Fragaria×ananassa).

Sargent DJ, Yang Y, Šurbanovski N, Bianco L, Buti M, Velasco R, Giongo L, Davis TM.

Plant Sci. 2016 Jan;242:140-50. doi: 10.1016/j.plantsci.2015.07.004. Epub 2015 Jul 10.


Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients.

Liu H, Tan AD, Qin R, Sargent DJ, Grothey A, Buckner JC, Schaefer PL, Sloan JA.

SOJ Anesthesiol Pain Manag. 2015;2(2). doi: 10.15226/2374-684X/2/2/00120. Epub 2015 Apr 10.


Mapping QTL associated with Verticillium dahliae resistance in the cultivated strawberry (Fragaria × ananassa).

Antanaviciute L, Šurbanovski N, Harrison N, McLeary KJ, Simpson DW, Wilson F, Sargent DJ, Harrison RJ.

Hortic Res. 2015 Mar 11;2:15009. doi: 10.1038/hortres.2015.9. eCollection 2015.


Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database.

Renfro LA, Loupakis F, Adams RA, Seymour MT, Heinemann V, Schmoll HJ, Douillard JY, Hurwitz H, Fuchs CS, Diaz-Rubio E, Porschen R, Tournigand C, Chibaudel B, Falcone A, Tebbutt NC, Punt CJ, Hecht JR, Bokemeyer C, Van Cutsem E, Goldberg RM, Saltz LB, de Gramont A, Sargent DJ, Lenz HJ.

J Clin Oncol. 2015 Oct 26. pii: JCO.2015.61.6441. [Epub ahead of print]


Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods.

An MW, Han Y, Meyers JP, Bogaerts J, Sargent DJ, Mandrekar SJ.

J Clin Oncol. 2015 Dec 1;33(34):4048-57. doi: 10.1200/JCO.2015.60.8778. Epub 2015 Oct 26.


Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial.

Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H.

JAMA. 2015 Oct 6;314(13):1346-55. doi: 10.1001/jama.2015.10529.


Introduction to special issue on biomarker-based clinical trial designs in oncology.

Sargent DJ, Mandrekar S, Grothey A.

Chin Clin Oncol. 2015 Sep;4(3):28. doi: 10.3978/j.issn.2304-3865.2015.09.05. No abstract available.


A ddRAD Based Linkage Map of the Cultivated Strawberry, Fragaria xananassa.

Davik J, Sargent DJ, Brurberg MB, Lien S, Kent M, Alsheikh M.

PLoS One. 2015 Sep 23;10(9):e0137746. doi: 10.1371/journal.pone.0137746. eCollection 2015.


Key statistical concepts in cancer research.

Shi Q, Sargent DJ.

Clin Adv Hematol Oncol. 2015 Mar;13(3):180-5.


Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups.

Wang X, Gu L, Zhang Y, Sargent DJ, Richards W, Ganti AK, Crawford J, Cohen HJ, Stinchcombe T, Vokes E, Pang H.

Lung Cancer. 2015 Nov;90(2):281-7. doi: 10.1016/j.lungcan.2015.08.007. Epub 2015 Aug 18.


Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival.

An MW, Dong X, Meyers J, Han Y, Grothey A, Bogaerts J, Sargent DJ, Mandrekar SJ; Response Evaluation Criteria in Solid Tumors Steering Committee.

J Natl Cancer Inst. 2015 Aug 21;107(11). pii: djv239. doi: 10.1093/jnci/djv239. Print 2015 Nov.


Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance).

Sinicrope FA, Mahoney MR, Yoon HH, Smyrk TC, Thibodeau SN, Goldberg RM, Nelson GD, Sargent DJ, Alberts SR; Alliance for Clinical Trials in Oncology.

Clin Cancer Res. 2015 Jul 17. [Epub ahead of print]


Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.

Tabernero J, Lenz HJ, Siena S, Sobrero A, Falcone A, Ychou M, Humblet Y, Bouché O, Mineur L, Barone C, Adenis A, Yoshino T, Goldberg RM, Sargent DJ, Wagner A, Laurent D, Teufel M, Jeffers M, Grothey A, Van Cutsem E.

Lancet Oncol. 2015 Aug;16(8):937-48. doi: 10.1016/S1470-2045(15)00138-2. Epub 2015 Jul 13.


Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients.

Yoon HH, Shi Q, Alberts SR, Goldberg RM, Thibodeau SN, Sargent DJ, Sinicrope FA; Alliance for Clinical Trials in Oncology.

J Natl Cancer Inst. 2015 Jul 9;107(10). pii: djv186. doi: 10.1093/jnci/djv186. Print 2015 Oct.


The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment.

Janes H, Pepe MS, McShane LM, Sargent DJ, Heagerty PJ.

J Natl Cancer Inst. 2015 Jun 24;107(8). pii: djv157. doi: 10.1093/jnci/djv157. Print 2015 Aug.


Comment on: 'evaluation of chemoresponse assays as predictive markers'.

Tian C, Gabrin MJ, Brower SL, Sargent DJ.

Br J Cancer. 2015 Jun 9;112(12):1977-8. doi: 10.1038/bjc.2015.156. Epub 2015 May 19. No abstract available.


Genotype-based clinical trials in cardiovascular disease.

Pereira NL, Sargent DJ, Farkouh ME, Rihal CS.

Nat Rev Cardiol. 2015 Aug;12(8):475-87. doi: 10.1038/nrcardio.2015.64. Epub 2015 May 5. Review.


Development and preliminary evaluation of a 90 K Axiom® SNP array for the allo-octoploid cultivated strawberry Fragaria × ananassa.

Bassil NV, Davis TM, Zhang H, Ficklin S, Mittmann M, Webster T, Mahoney L, Wood D, Alperin ES, Rosyara UR, Koehorst-Vanc Putten H, Monfort A, Sargent DJ, Amaya I, Denoyes B, Bianco L, van Dijk T, Pirani A, Iezzoni A, Main D, Peace C, Yang Y, Whitaker V, Verma S, Bellon L, Brew F, Herrera R, van de Weg E.

BMC Genomics. 2015 Mar 7;16:155. doi: 10.1186/s12864-015-1310-1.


Adaptive randomized phase II design for biomarker threshold selection and independent evaluation.

Renfro LA, Coughlin CM, Grothey AM, Sargent DJ.

Chin Clin Oncol. 2014 Mar;3(1):3. doi: 10.3978/j.issn.2304-3865.2013.12.04.


Overview: biostatistician's role in oncology clinical trials-strive for sound, efficient and practical studies.

Shi Q, Sargent DJ.

Chin Clin Oncol. 2014 Mar;3(1):1. doi: 10.3978/j.issn.2304-3865.2013.12.03. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk